WHO WE ARE
Chief Science Officer
Chief Executive Officer
Chief Executive Officer Jeff Davidson holds a B.S. in chemical engineering from Purdue University and an M.B.A. from the University of Minnesota. His 32 years of experience in industry and academia include serving as the Executive Director of the Penn State Bioprocessing Resource Center; founder and Executive Director of the Pennsylvania Biotechnology Association; publisher of Your World, a biotechnology applications magazine; founder of the Biotechnology Institute, a national biotechnology education nonprofit; and founder of BioSciEd Inc. Mr. Davidson co-founded Keystone Nano and has served as its CEO since inception.
Chief Science Officer James H. Adair is a key creator of the Keystone Nano technology, has published extensively in materials chemistry and nanobiology subjects with over 250 publications, and holds 13 patents. He has a B.S. in Chemistry and Ph.D. in Materials Science and Engineering from the University of Florida. Dr. Adair was a Fulbright Post-doctoral Fellow in the Royal Perth Hospital at the University of Western Australia. With more than 40 years of nanoparticle experience, he is Director of the Center for Nanomedicine and Materials and a Professor of Materials Science and Engineering, Biomedical Engineering, and Pharmacology at Penn State University. Dr. Adair is a co-founder of Keystone Nano.
Chief Medical Officer Mark Kester earned his B.S. in biology and economics from the State University of New York at Stony Brook and his Ph.D. in biochemistry from SUNY at Buffalo. Following an initial faculty position at Case Western Reserve University, he moved on to Penn State University in 1998, where he served as the Passananti Professor of Pharmacology, Director of the Penn State Center for Nanomedicine and Materials and the co-leader for Experimental Therapeutics at the Hershey Cancer Institute. Dr. Kester joined the faculty at the University of Virginia in 2014 as a Professor of Pharmacology and the director of the NanoSTAR Institute. Dr. Kester is a co-founder of Keystone Nano and oversees the company’s technology development associated with medical applications.
Vice President of Business Development Jim Sharpe has co-founded 3 biotechnology companies and has also been Chief Operating Officer, President or CEO of 3 biopharmaceutical companies. He has initiated, negotiated and closed over 40 transactions valued at over $200 million including mergers, acquisitions, R&D partnerships, product development collaborations, in and out-licensing, co-marketing, distribution and manufacturing agreements. He has also raised over $25 million in financing (capital raising) for start-up and emerging companies. He holds a B.S. in Chemistry from Union College and an MBA in Marketing & Finance from the University of Rochester.
Chief Medical Officer
VP of Business Development
Senior Bio Researcher
Senior Biological Researcher Jocelyn Bassler specializes in liposome synthesis as well as developing cell-based assays and new techniques for particle analysis. She received her B.S. in Biology from Virginia Tech (also earning a minor in Entomology) and has over 15 years of research experience. Prior to joining Keystone Nano in 2010, Jocelyn spent seven years at Southern Research Institute in Maryland where she worked as a biologist in their infectious disease research division. Her work there included immunological analyses at BSL-2 and BSL-3 levels for a wide range of infectious agents including HIV, Avian Influenza, West Nile, pox viruses, and Y. pestis. She is now developing new cancer therapies working at the intersection of biology, nano-scale materials, and medicine for Keystone Nano.